Cited by 122Bipolar Disorder and TreatmentSchizophrenia research and treatmentTreatment of Major Depression

PET Study of [18F]6-Fluoro-l-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium

Yatham, Lakshmi N., Liddle, Peter F., Shiah, I-Shin, Lam, Raymond W., Ngan, Elton, Scarrow, Gayle, Imperial, Miguel, Stoessl, Jon +2 more·2002·American Journal of Psychiatry

Abstract

OBJECTIVE: Although dopaminergic hyperactivity has been implicated in mania, the precise location in the brain of the abnormality is unclear. This study assessed presynaptic dopamine function in neuroleptic- and mood-stabilizer-naive nonpsychotic first-episode manic patients before and after treatment with divalproex sodium by measuring [(18)F]6-fluoro-L-dopa ([(18)F]DOPA) uptake in the striatum with positron emission tomography (PET). METHOD: Thirteen patients with DSM-IV bipolar I disorder, manic episode, and 13 healthy comparison subjects underwent [(18)F]DOPA PET scans. Ten of the 13 patients had repeat PET scans 2-6 weeks after beginning treatment with divalproex sodium monotherapy. [(18)F]DOPA uptake rate constants (K(i) values) in the striatum were calculated by using graphical analysis with activity from the occipital cortex as the input function. RESULTS: No significant differences in [(18)F]DOPA uptake rate constants in the striatum were found between the manic patients and the comparison subjects. After treatment with divalproex sodium, [(18)F]DOPA rate constants were significantly reduced in the patients and were lower in the patients than in the comparison subjects. CONCLUSIONS: Although presynaptic dopamine function as reflected by [(18)F]DOPA uptake is not altered in mania, presynaptic dopamine function in manic patients was lower after treatment with divalproex sodium.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.159.5.768

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The presence of psychosis may moderate patterns of DA receptor binding; striatal D2 receptor signaling seems greater in psychotic patients with bipolar disorder, whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls.

    “There is also evidence that the presence of psychosis may moderate patterns of DA receptor binding. Specifically, striatal D2 receptor signaling seems to be greater in psychotic patients with bipolar disorder [286,287], whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls [288,289].”

Cites

Flagged first, then by citations

1 of the 58 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yatham, L. N., Liddle, P. F., Shiah, I.-S., Lam, R. W., Ngan, E., Scarrow, G., Imperial, M., Stoessl, J., Sossi, V., & Ruth, T. J.
Affiliations
University of British Columbia (CA)
Venue
American Journal of Psychiatry
Published
2002-05-01
Volume
159
Issue
5
Pages
768-774
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2156766604
Cited by
122
References
58
Citations by year
2024: 1 · 2022: 1 · 2021: 26 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 3 · 2012: 4
FWCI
3.84
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
first-episode mania, divalproex sodium, striatal dopamine uptake, bipolar I disorder, neuroleptic-naive patients
MeSH terms
Adult, Age Factors, Anticonvulsants, Bipolar Disorder, Corpus Striatum, Dihydroxyphenylalanine, Dopamine, Female, Fluorine Radioisotopes, Humans, Male, Middle Aged, Tomography, Emission-Computed, Antipsychotic Agents, Valproic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review